Theriva Biologics, Inc. (TOVX)

USD 1.05

(-2.78%)

Revenue Summary of Theriva Biologics, Inc.

  • Theriva Biologics, Inc.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Theriva Biologics, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Theriva Biologics, Inc. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Theriva Biologics, Inc. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Theriva Biologics, Inc. reported a quarterly revenue of - USD for 2024 Q1, down -100.0% from previous quarter.
  • Theriva Biologics, Inc. reported a quarterly revenue of 758 Thousand USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Theriva Biologics, Inc. (2023 - 1993)

Historical Annual Revenue of Theriva Biologics, Inc. (2023 - 1993)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 3.16 Million USD 2969.69%
2009 103.08 Thousand USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2002 10 Thousand USD -98.86%
2001 874.09 Thousand USD 72.55%
2000 506.57 Thousand USD 26.84%
1999 399.37 Thousand USD -0.16%
1998 400 Thousand USD -20.0%
1997 500 Thousand USD 0.0%
1996 500 Thousand USD 400.0%
1995 100 Thousand USD 0.0%
1994 100 Thousand USD 0.0%
1993 100 Thousand USD 0.0%

Peer Revenue Comparison of Theriva Biologics, Inc.

Name Revenue Revenue Difference
AIM ImmunoTech Inc. 202 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Armata Pharmaceuticals, Inc. 4.52 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 81 Thousand USD 100.0%
Azitra, Inc. 686 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 743 Thousand USD 100.0%
Chromocell Therapeutics Corporation - USD NaN%
Calidi Biotherapeutics, Inc. - USD NaN%
CEL-SCI Corporation - USD NaN%
iBio, Inc. 225 Thousand USD 100.0%
Lineage Cell Therapeutics, Inc. 8.94 Million USD 100.0%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. 1.09 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 100.0%
NovaBay Pharmaceuticals, Inc. 14.72 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. 37.65 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
Protalix BioTherapeutics, Inc. 65.49 Million USD 100.0%
Palatin Technologies, Inc. 4.49 Million USD 100.0%
Scorpius Holdings, Inc. 6.99 Million USD 100.0%